ABCLAbCellera Biologics Inc.
Is it safe?
Mostly sound, with a caveat: insiders buying, but big price swings.
Multiple insiders bought with their own money (net +$1.5M, 90 days to Oct 8, 2026).
Large price swings, high volatility. Worst drawdown -97% · now 15% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can ABCL take a bad year?
The deepest fall in ABCL's price history on file is −97%; it is 15% below its high today.
Worst drawdown on file · −15% today
- Cash runway
- 1.0 years
Cash runway · burning $30M a quarter at the current rate
- Annualised volatility
- 79%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $120M
- Operating profit, trailing twelve months
- −$225M
- Annualised volatilitytwo years of daily moves
- 79%
- Worst drawdown on file
- −97%
- Below its 52-week high
- 15%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.